Kramar A - Search Results

1

Acute tumor lysis syndrome in poor-risk germ cell tumors: does it exist?

Kattan J, Culine S, Tavakoli-Razavi T, Kramar A, Droz JP. Kattan J, et al. Among authors: kramar a. Support Care Cancer. 1994 Mar;2(2):128-31. doi: 10.1007/BF00572095. Support Care Cancer. 1994. PMID: 7512416

2

Salvage chemotherapy in refractory germ cell tumors with etoposide (VP-16) plus ifosfamide plus high-dose cisplatin. A VIhP regimen.

Ghosn M, Droz JP, Theodore C, Pico JL, Baume D, Spielmann M, Ostronoff M, Moran A, Salloum E, Kramar A, et al. Ghosn M, et al. Among authors: kramar a. Cancer. 1988 Jul 1;62(1):24-7. doi: 10.1002/1097-0142(19880701)62:1<24::aid-cncr2820620106>3.0.co;2-y. Cancer. 1988. PMID: 3133101

3

High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumours.

Kattan J, Mahjoubi M, Droz JP, Kramar A, Culine S, Boutan-Laroze A, Chazard M. Kattan J, et al. Among authors: kramar a. Eur J Cancer. 1993;29A(11):1504-9. doi: 10.1016/0959-8049(93)90283-l. Eur J Cancer. 1993. PMID: 8217352 Clinical Trial.

4

Prediction of long-term response after high-dose chemotherapy with autologous bone marrow transplantation in the salvage treatment of non-seminomatous germ cell tumours.

Droz JP, Kramar A, Pico JL. Droz JP, et al. Among authors: kramar a. Eur J Cancer. 1993;29A(6):818-21. doi: 10.1016/s0959-8049(05)80416-2. Eur J Cancer. 1993. PMID: 8387318

5

High-dose chemotherapy in germ-cell tumors.

Droz JP, Culine S, Biron P, Kramar A. Droz JP, et al. Among authors: kramar a. Ann Oncol. 1996 Dec;7(10):997-1003. doi: 10.1093/oxfordjournals.annonc.a010523. Ann Oncol. 1996. PMID: 9037356 Free article. Review.

6

Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy.

Fizazi K, Culine S, Droz JP, Kramar A, Théodore C, Ruffié P, Le Chevalier T. Fizazi K, et al. Among authors: kramar a. J Clin Oncol. 1998 Feb;16(2):725-32. doi: 10.1200/JCO.1998.16.2.725. J Clin Oncol. 1998. PMID: 9469363

7

A phase II trial of early intensive chemotherapy with autologous bone marrow transplantation in the treatment of poor prognosis non seminomatous germ cell tumors.

Droz JP, Pico JL, Ghosn M, Kramar A, Rey A, Ostronoff M, Baume D. Droz JP, et al. Among authors: kramar a. Bull Cancer. 1992;79(5):497-507. Bull Cancer. 1992. PMID: 1421710 Clinical Trial.

8

Prognostic factors in advanced nonseminomatous testicular cancer. A multivariate logistic regression analysis.

Droz JP, Kramar A, Ghosn M, Piot G, Rey A, Theodore C, Wibault P, Court BH, Perrin JL, Travagli JP, et al. Droz JP, et al. Among authors: kramar a. Cancer. 1988 Aug 1;62(3):564-8. doi: 10.1002/1097-0142(19880801)62:3<564::aid-cncr2820620321>3.0.co;2-a. Cancer. 1988. PMID: 2455591

9

[Prognostic factors for extratesticular involvement in stage I testicular cancer. Apropos of 58 cases].

Chraibi Y, Culine S, Terrier-Lacombe MJ, Kramar A, Kattan J, Droz JP. Chraibi Y, et al. Among authors: kramar a. Bull Cancer. 1994 Apr;81(4):311-7. Bull Cancer. 1994. PMID: 7703548 French.

10

Role of autologous bone marrow transplantation in germ-cell cancer.

Droz JP, Pico JL, Kramar A. Droz JP, et al. Among authors: kramar a. Urol Clin North Am. 1993 Feb;20(1):161-71. Urol Clin North Am. 1993. PMID: 8381996 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters